Alkeon Capital Management - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$163,626,000
+289.4%
4,616,975
+48.1%
0.41%
+131.3%
Q1 2020$42,017,000
-30.7%
3,116,975
+8.7%
0.18%
-20.8%
Q4 2019$60,665,000
+87.3%
2,866,975
+17.4%
0.23%
+98.2%
Q3 2019$32,381,000
+20.2%
2,441,975
+25.7%
0.11%
+6.5%
Q2 2019$26,935,000
-27.8%
1,941,9750.0%0.11%
-42.5%
Q1 2019$37,305,000
+98.5%
1,941,975
+47.5%
0.19%
+52.5%
Q4 2018$18,793,000
-54.9%
1,316,975
-34.2%
0.12%
-38.1%
Q3 2018$41,665,000
-4.9%
2,000,235
+8.1%
0.20%
-3.4%
Q2 2018$43,790,0001,850,0000.20%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders